Verruca Vulgaris Clinical Trial
Official title:
Is Involucrin Has a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study
Vitamin D3 plays important role in keratinocyte differentiation and had been used recently in verruca vulgaris. Aim of the work: To assess the expression of involucrin in verrucae vulgaris before and after injection of vitamin D3. Subjects and Methods: This study included 60 patients with verrucae vulgaris subjected to intralesional injection of vitamin D3 at three weeks interval for a maximum of five sessions. Immunohistochemical assessment of involucrin was done before and after injection and compared to skin biopsies from 30 healthy individuals
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05937672 -
Cold Atmospheric Plasma Device Extension Study
|
Phase 3 | |
| Completed |
NCT00328991 -
Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts
|
N/A | |
| Recruiting |
NCT05409365 -
Assessment of Squamous Cell Carcinoma antigen2 in Verruca Vulgaris
|
||
| Completed |
NCT03487549 -
Cantharidin and Occlusion in Verruca Epithelium
|
Phase 2 | |
| Completed |
NCT01084824 -
A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin
|
N/A | |
| Terminated |
NCT01609530 -
Pulsed 1064nm Nd:YAG in the Treatment of Verruca Vulgaris Versus Conventional Therapy With Liquid Nitrogen Cryotherapy
|
N/A | |
| Recruiting |
NCT04620785 -
Photodynamic Therapy in Treatment of Verrucae
|
N/A | |
| Recruiting |
NCT05799157 -
Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts
|
Phase 2 | |
| Completed |
NCT05070754 -
Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca
|
Phase 4 | |
| Completed |
NCT02748902 -
Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands.
|
Phase 1 | |
| Completed |
NCT02483455 -
ALC-919 For The Treatment Of Common Warts
|
Phase 2 |